Therapy of Metastatic Melanoma by Adressing Tolerance Inducing Macrophages
Laufzeit: 01.01.2013 - 31.12.2013
imported
Kurzfassung
SFB1066 “Nanodimensional Therapeutics for Cancer Therapy”: “Therapy of Metastatic Melanoma by Adressing Tolerance Inducing Macrophages“.
